A detailed history of Blackston Financial Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Blackston Financial Advisory Group, LLC holds 4,711 shares of ABBV stock, worth $847,980. This represents 0.49% of its overall portfolio holdings.

Number of Shares
4,711
Previous 4,275 10.2%
Holding current value
$847,980
Previous $733,000 26.88%
% of portfolio
0.49%
Previous 0.45%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $71,434 - $86,907
436 Added 10.2%
4,711 $930,000
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $485,731 - $567,224
3,138 Added 275.99%
4,275 $733,000
Q1 2024

Jul 17, 2024

SELL
$159.82 - $182.1 $359,914 - $410,089
-2,252 Reduced 66.45%
1,137 $207,000
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $13,265 - $15,114
-83 Reduced 2.39%
3,389 $617,000
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $36,051 - $40,602
262 Added 8.16%
3,472 $538,000
Q3 2023

Jan 26, 2024

SELL
$133.59 - $154.65 $5,744 - $6,649
-43 Reduced 1.24%
3,429 $511,000
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $44,920 - $55,901
-339 Reduced 9.55%
3,210 $432,000
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $23,716 - $27,312
-164 Reduced 4.42%
3,549 $566,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $12,171 - $14,596
-88 Reduced 2.32%
3,713 $600,000
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $38,518 - $44,177
287 Added 8.17%
3,801 $557,000
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $136,794 - $173,910
994 Added 39.44%
3,514 $534,000
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $50,020 - $62,061
-379 Reduced 13.07%
2,520 $272,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $311,439 - $394,061
2,899 New
2,899 $393,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Blackston Financial Advisory Group, LLC Portfolio

Follow Blackston Financial Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackston Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blackston Financial Advisory Group, LLC with notifications on news.